Kewaunee Scientific (NASDAQ:KEQU) versus CardioGenics (OTCMKTS:CGNH) Financial Contrast

CardioGenics (OTCMKTS:CGNH) and Kewaunee Scientific (NASDAQ:KEQU) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Earnings & Valuation

This table compares CardioGenics and Kewaunee Scientific”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CardioGenics	N/A	N/A	N/A	N/A	N/A
Kewaunee Scientific	$282.00 million	0.37	$9.62 million	$3.22	11.24

Kewaunee Scientific has higher revenue and earnings than CardioGenics.

Analyst Recommendations

This is a summary of recent ratings for CardioGenics and Kewaunee Scientific, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CardioGenics	0	0	0	0	0.00
Kewaunee Scientific	0	1	0	0	2.00

Institutional & Insider Ownership

32.7% of Kewaunee Scientific shares are held by institutional investors. 41.4% of CardioGenics shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares CardioGenics and Kewaunee Scientific’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CardioGenics	N/A	N/A	N/A
Kewaunee Scientific	3.41%	14.10%	5.55%

Volatility and Risk

CardioGenics has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Kewaunee Scientific has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

Summary

Kewaunee Scientific beats CardioGenics on 7 of the 8 factors compared between the two stocks.

About CardioGenics

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.